ArticleJournal of multidisciplinary healthcare2025
Body Mass Index, Cardiac Reverse Remodeling, and Outcomes with Cardiac Resynchronization Therapy in Heart Failure: Insights from Two-Dimensional Speckle-Tracking Echocardiography.
Article in Journal of multidisciplinary healthcare, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to evaluate the effects of cardiac resynchronization therapy (CRT) on cardiac reverse remodeling and long-term clinical outcomes in individuals with advanced heart failure, stratified by body mass index (BMI), using two-dimensional speckle-tracking echocardiography. Methods: In this retrospective, single-center study, a cohort of 141 patients with heart failure who underwent CRT implantation between 2008 and 2014 was categorized into 4 BMI groups. Clinical and echocardiographic parameters were assessed at baseline and six months post-therapy. Strain analyses of the left atrium and left ventricle were performed using EchoPAC, and long-term clinical outcomes were recorded. Results: Participants classified as overweight (BMI 24-28 kg/m²) or obese (BMI ≥ 28 kg/m²) demonstrated greater improvements in clinical status and echocardiographic strain measures ( Conclusion: CRT was associated with greater clinical and echocardiographic benefits in patients with higher BMI, and LAScd was identified as a key predictor of therapeutic response and long-term prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.